tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Retrognathia D063173 1 associated lipids
Drug-Related Side Effects and Adverse Reactions D064420 3 associated lipids
Scorpion Stings D065008 1 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Hatanaka H and Shimomura K [Immunosuppressive activity of a microbial product]. 1997 Nippon Yakurigaku Zasshi pmid:9503409
Devine SM et al. The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis. 1997 Biol. Blood Marrow Transplant. pmid:9209738
Su Y et al. Cyclosporin A but not FK506 inhibits thyroid hormone-induced apoptosis in tadpole intestinal epithelium. 1997 FASEB J. pmid:9212079
Maeda T [Experimental study of the effectiveness of immunosuppression therapy using FK506 and 15-deoxyspergualin in concordant xenotransplantation]. 1997 Nihon Kyobu Geka Gakkai Zasshi pmid:9217381
duBell WH et al. Effect of the immunosupressant FK506 on excitation-contraction coupling and outward K+ currents in rat ventricular myocytes. 1997 J. Physiol. (Lond.) pmid:9218211
de-la-Serna-Higuera C et al. Tacrolimus-induced bone marrow suppression. 1997 Lancet pmid:9291912
Yoshikawa H et al. Fc gammaRIII-mediated regulation of hematopoiesis in murine bone marrow cells by interleukin-3 and CD95 (Fas/Apo-1). 1997 Blood pmid:9292524
Jain A et al. Pregnancy after liver transplantation under tacrolimus. 1997 Transplantation pmid:9293865
Garcia-Criado FJ et al. Tacrolimus (FK506) down-regulates free radical tissue levels, serum cytokines, and neutrophil infiltration after severe liver ischemia. 1997 Transplantation pmid:9293871
Suzuki H et al. Induction of transplantation tolerance in adult rats by vascularized spleen transplantation. 1997 Transplantation pmid:9293881
Alvaro D et al. Role and mechanisms of action of acetylcholine in the regulation of rat cholangiocyte secretory functions. 1997 J. Clin. Invest. pmid:9294100
Ruzicka T et al. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. 1997 N. Engl. J. Med. pmid:9295241
Birnbaum AH et al. Recurrence of autoimmune hepatitis in children after liver transplantation. 1997 J. Pediatr. Gastroenterol. Nutr. pmid:9226522
Alarcón CM and Heitman J FKBP12 physically and functionally interacts with aspartokinase in Saccharomyces cerevisiae. 1997 Mol. Cell. Biol. pmid:9315655
Scott JE et al. Dynamic equilibrium between calcineurin and kinase activities regulates the phosphorylation state and localization of the nuclear factor of activated T-cells. 1997 Biochem. J. pmid:9182723
Goodyear N et al. The 37 kDa immunophilin has uracil DNA glycosylase but not rotamase activity. 1997 Clin. Biochem. pmid:9316745
Suzuki N et al. In vivo mechanisms for the inhibition of T lymphocyte activation by long-term therapy with tacrolimus (FK-506): experience in patients with Behçet's disease. 1997 Arthritis Rheum. pmid:9182928
Rudi J et al. Prevalence of serum antibodies to Helicobacter pylori and to CagA protein in liver transplant recipients. 1997 Am. J. Gastroenterol. pmid:9317070
Odom A et al. Calcineurin is required for virulence of Cryptococcus neoformans. 1997 EMBO J. pmid:9184205
Kesten S et al. Tacrolimus as rescue therapy for bronchiolitis obliterans syndrome. 1997 J. Heart Lung Transplant. pmid:9322139
Nishinaka H et al. Graft persistence effectively induces and maintains donor-specific unresponsiveness. 1997 J. Surg. Res. pmid:9184673
Cardoso CM et al. Uncoupling of Ca2+ transport ATPase in muscle and blood platelets by diacylglycerol analogues and cyclosporin A antagonism. 1997 Biochem. J. pmid:9581558
Ko WJ et al. Hypomagnesia and arrhythmia corrected by replacing cyclosporine with FK506 in a heart transplant recipient. 1997 J. Heart Lung Transplant. pmid:9322151
Miwa S et al. Effect of anti-intercellular adhesion molecule-1 and anti-leukocyte function associated antigen-1 monoclonal antibodies on rat-to-mouse cardiac xenograft rejection. 1997 Surgery pmid:9186469
Arbustini E et al. Acute rejection and heart infection rates in FK 506- versus cyclosporine A-treated heart transplant recipients: an endomyocardial biopsy pathologic study. 1997 J. Heart Lung Transplant. pmid:9322152
Fujino H et al. Stimulatory roles of muscarinic acetylcholine receptors on T cell antigen receptor/CD3 complex-mediated interleukin-2 production in human peripheral blood lymphocytes. 1997 Mol. Pharmacol. pmid:9187267
Denecker G et al. Differential role of calcium in tumour necrosis factor-mediated apoptosis and secretion of granulocyte-macrophage colony-stimulating factor in a T cell hybridoma. 1997 Cytokine pmid:9325011
Hausen B and Morris RE Review of immunosuppression for lung transplantation. Novel drugs, new uses for conventional immunosuppressants, and alternative strategies. 1997 Clin. Chest Med. pmid:9187827
Fujita T et al. Prolonged survival of rat skin allograft by treatment with FK506 ointment. 1997 Transplantation pmid:9326422
Pratschke J et al. Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation. 1997 Transplantation pmid:9326428
Raufman JP et al. Regulation of calcium-induced exocytosis from gastric chief cells by protein phosphatase-2B (calcineurin). 1997 Biochim. Biophys. Acta pmid:9202177
McGhee B et al. Therapeutic use of an extemporaneously prepared oral suspension of tacrolimus in pediatric patients. 1997 Transplantation pmid:9326429
Mochizuki M Immunotherapy for Behçet's disease. 1997 Int. Rev. Immunol. pmid:9203026
Braun F et al. Pitfalls in monitoring tacrolimus (FK 506). 1997 Ther Drug Monit pmid:9421102
Guckelberger O et al. Cardiovascular risk factors in long-term follow-up after orthotopic liver transplantation. 1997 Clin Transplant pmid:9067697
Mueller AR et al. Association between hepatitis and rejection: upregulation of cytokines and extracellular matrix parameters. 1997 Transplant. Proc. pmid:9365585
Singh N et al. Clinical spectrum of invasive cryptococcosis in liver transplant recipients receiving tacrolimus. 1997 Clin Transplant pmid:9067698
Platz KP et al. FK 506 and mycofenolate mofetil rescue for acute steroid-resistant and chronic rejection after liver transplantation. 1997 Transplant. Proc. pmid:9365598
Victor RG et al. Mechanism of Ca(2+)-dependent inactivation of L-type Ca2+ channels in GH3 cells: direct evidence against dephosphorylation by calcineurin. 1997 J. Membr. Biol. pmid:9070464
Platz KP et al. Indications for mycofenolate mofetil therapy after liver transplantation. 1997 Transplant. Proc. pmid:9365601
Demirbas A et al. FK 506 in simultaneous pancreas/kidney transplantation: the University of Miami experience. 1997 Transplant. Proc. pmid:9365608
Ferron GM et al. Population pharmacokinetics of sirolimus in kidney transplant patients. 1997 Clin. Pharmacol. Ther. pmid:9129559
Kliem V et al. Long-term results after primary successful FK 506 treatment of steroid- and OKT3-resistant rejection in renal transplant recipients. 1997 Transplant. Proc. pmid:9365627
Weil SJ et al. Chemotaxis of macrophages by a peritoneal fluid protein in women with endometriosis. 1997 Fertil. Steril. pmid:9130891
Xu M et al. Effect of peritransplant FTY720 alone or in combination with posttransplant FK 506 in a rat model of cardiac allotransplantation. 1997 Transplant. Proc. pmid:9365631
Karlsson H et al. Energy levels in resting and mitogen-stimulated human lymphocytes during treatment with FK506 or cyclosporin A in vitro. 1997 Biochim. Biophys. Acta pmid:9131051
Gavlik A et al. Mycophenolate mofetil rescue therapy in liver transplant recipients: an extended follow-up. 1997 Transplant. Proc. pmid:9365633
Pratt WB The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase. 1997 Annu. Rev. Pharmacol. Toxicol. pmid:9131255
Lee CM et al. Outcomes in diabetic patients after simultaneous pancreas-kidney versus kidney alone transplantation. 1997 Transplantation pmid:9371670
Niederstadt C et al. Effect of FK506 on magnesium homeostasis after renal transplantation. 1997 Transplant. Proc. pmid:9365709
Filler G et al. Transient diabetes mellitus and peripheral insulin resistance following Tacrolimus intoxication in a child after renal transplantation. 1997 Nephrol. Dial. Transplant. pmid:9132657
Takao T et al. [A case of recurrent IgA nephropathy following renal transplantation under tacrolimus (FK506)]. 1997 Hinyokika Kiyo pmid:9365847
Yap AS et al. Lateral clustering of the adhesive ectodomain: a fundamental determinant of cadherin function. 1997 Curr. Biol. pmid:9133345
Aoyama S et al. [The effect of FK 506, an immunosuppressant, on cerebral infarction volume in focal cerebral ischemia in rats]. 1997 Nippon Ika Daigaku Zasshi pmid:9366145
Ross DJ et al. FK 506 'rescue' immunosuppression for obliterative bronchiolitis after lung transplantation. 1997 Chest pmid:9367453
Tomás ML [Immunosuppressive agents: side effects]. 1997 An R Acad Nac Med (Madr) pmid:9616947
Singh N et al. Bloodstream infections in liver transplant recipients receiving tacrolimus. 1997 Clin Transplant pmid:9267715
Guo Z et al. In vivo effects of leflunomide on normal pancreatic islet and syngeneic islet graft function. 1997 Transplantation pmid:9075844
Gruessner RW Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. 1997 Clin Transplant pmid:9267719
Ciancio G et al. Use of intravenous FK506 to treat acute rejection in simultaneous pancreas-kidney transplant recipients on maintenance oral FK506. 1997 Transplantation pmid:9075856
Sherrington PD et al. TLiSA1 (PTA1) activation antigen implicated in T cell differentiation and platelet activation is a member of the immunoglobulin superfamily exhibiting distinctive regulation of expression. 1997 J. Biol. Chem. pmid:9268302
Mirza DF et al. Reduced acute rejection after liver transplantation with Neoral-based triple immunosuppression. 1997 Lancet pmid:9078209
Danovitch GM Cyclosporin or tacrolimus: which agent to choose? 1997 Nephrol. Dial. Transplant. pmid:9269630
Yoshikawa H et al. FK506 prevents induction of rat experimental autoimmune myasthenia gravis. 1997 J. Autoimmun. pmid:9080295
Filler G et al. Pharmacokinetics of tacrolimus (FK 506) in children and adolescents with renal transplants. 1997 Nephrol. Dial. Transplant. pmid:9269646
Yokoyama I et al. Fas antigen expression of hepatocytes and its modification by immunosuppressants. 1997 Dig. Dis. Sci. pmid:9440622
Sperr WR et al. Inhibition of allergen-induced histamine release from human basophils by cyclosporine A and FK-506. 1997 Int. Arch. Allergy Immunol. pmid:9303333
Azuma H et al. Atypical Epstein-Barr virus infection during and after intermittent FK506 therapy. 1997 Acta Paediatr Jpn pmid:9141259
Izuishi K et al. Effects of an immunosuppressive agent, tacrolimus (FK-506), on the activities of cytochrome P-450-linked monooxygenase systems in rat liver microsomes. 1997 Int. J. Biochem. Cell Biol. pmid:9304807
Tsuchida Y et al. Vascularized bone marrow allotransplantation in rats prolongs a simultaneous skin allograft. 1997 Transplant. Proc. pmid:9142252
Jonas S et al. De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin. 1997 Cancer pmid:9305716
Costa A et al. Small bowel myoelectrical activity after transplantation in pigs: motility versus ACR score. 1997 Transplant. Proc. pmid:9142281
Tze WJ et al. Prolongation of pig islet xenograft survival in rats immunosuppressed with FK506. 1997 Diabetes Res. Clin. Pract. pmid:9306035
Soin AS et al. Complement activation during rejection in experimental intestinal transplantation. 1997 Transplant. Proc. pmid:9142282
Tanaka H et al. [Discovery and development of a novel immunosuppressant, tacrolimus hydrate]. 1997 Yakugaku Zasshi pmid:9306728
Rossi G et al. Small bowel transplantation under oral immunosuppression: experimental study in the pig. 1997 Transplant. Proc. pmid:9142285
Kamada H et al. Immunopharmacological studies on collagen-induced arthritis in dark Agouti (DA) rats. 1997 Jpn. J. Pharmacol. pmid:9307327
Spada M et al. Tacrolimus and mycophenolate mofetil in pig small bowel transplantation: different protocols and their outcome. 1997 Transplant. Proc. pmid:9142286
Ronchetti F et al. Intestinal damage evaluation in swine allograft small bowel through hyaluronic acid quantification. 1997 Transplant. Proc. pmid:9142293
McKee M et al. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients. 1997 J. Pediatr. Surg. pmid:9165452
Uno T et al. The pharmacokinetics of water-in-oil-in-water-type multiple emulsion of a new tacrolimus formulation. 1997 Lipids pmid:9168461
Gold BG FK506 and the role of immunophilins in nerve regeneration. 1997 Mol. Neurobiol. pmid:9457703
Jiang H et al. Distinct tissue and cellular distribution of two major isoforms of calcineurin. 1997 Mol. Immunol. pmid:9393969
Schweda F et al. Tacrolimus treatment for steroid- and cyclosporin-resistant minimal-change nephrotic syndrome. 1997 Nephrol. Dial. Transplant. pmid:9394341
Sabatini DM et al. Neural roles of immunophilins and their ligands. 1997 Mol. Neurobiol. pmid:9396011
Su Y et al. Thyroid hormone induces apoptosis in primary cell cultures of tadpole intestine: cell type specificity and effects of extracellular matrix. 1997 J. Cell Biol. pmid:9396758
Yamaguchi Y et al. Enhanced expression of cytokine-induced neutrophil chemoattractant in rat hepatic allografts during acute rejection. 1997 Hepatology pmid:9397996
Mollison KW et al. Discovery of less nephrotoxic FK506 analogs and determining immunophilin dependence of immunosuppressant nephrotoxicity with a novel single-dose rat cisplatin potentiation assay. 1997 J. Pharmacol. Exp. Ther. pmid:9400028
Mondragon A et al. Overexpression and purification of human calcineurin alpha from Escherichia coli and assessment of catalytic functions of residues surrounding the binuclear metal center. 1997 Biochemistry pmid:9125515
Murthy JN et al. Identification of a 37 kDa tacrolimus, sirolimus and cyclosporine binding immunophilin possessing glyceraldehyde 3-phosphate dehydrogenase activity isolated from the Jurkat T cell line. 1997 Clin. Biochem. pmid:9127694
Odom A et al. The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein. 1997 Antimicrob. Agents Chemother. pmid:8980772
High KP and Washburn RG Invasive aspergillosis in mice immunosuppressed with cyclosporin A, tacrolimus (FK506), or sirolimus (rapamycin). 1997 J. Infect. Dis. pmid:8985226
Yoshikai Y et al. Clonal expansion of superantigen-reactive T cells is resistant to FK506 in mice with AIDS. 1997 J. Virol. pmid:8985410
Jordan ML et al. Tacrolimus rescue therapy for renal allograft rejection--five-year experience. 1997 Transplantation pmid:9020321
Noguchi N et al. Cyclic ADP-ribose binds to FK506-binding protein 12.6 to release Ca2+ from islet microsomes. 1997 J. Biol. Chem. pmid:9013543
Ishizuka T et al. Rapamycin potentiates dexamethasone-induced apoptosis and inhibits JNK activity in lymphoblastoid cells. 1997 Biochem. Biophys. Res. Commun. pmid:9016789
Bragado MJ et al. p70s6k is activated by CCK in rat pancreatic acini. 1997 Am. J. Physiol. pmid:9252447
Lacaille F et al. Life-threatening food allergy in a child treated with FK506. 1997 J. Pediatr. Gastroenterol. Nutr. pmid:9252915
Bagnis C et al. Comparative acute nephrotoxicity of FK-506 and ciclosporin in an isolated in situ autoperfused rat kidney model. 1997 Am. J. Nephrol. pmid:9057948
Rühlmann A and Nordheim A Effects of the immunosuppressive drugs CsA and FK506 on intracellular signalling and gene regulation. 1997 Immunobiology pmid:9442391